Establishment, culture and characterization of gemcitabine hydrochloride‐resistant human non‐small cell lung carcinoma cell line derived cancer stem cells
Authors:
- Bahar Demir CevizlidereBCBahar Demir Cevizlidere
- Onur UysalOUOnur Uysal
- Huseyin AvciHAHuseyin Avci
- Sibel Gunes BagisSBSibel Gunes Bagis
- Tugba Semerci SevimliTSTugba Semerci Sevimli
- Murat DincerMDMurat Dincer
- Emilia Qomi EkenelEEEmilia Qomi Ekenel
- Suleyman Gokhan KaraSKSuleyman Gokhan Kara
- Merve Nur SoykanMSMerve Nur Soykan
- Ayla Eker SariboyaciASAyla Eker Sariboyaci
Open Access
- 22 June 2024
- journal article
- research article
- Published by Wiley in Cell Biochemistry and Function
- Vol. 42 (4) , e4079
Abstract
Due to their high expression profile of multi‐drug resistance genes, cancer stem cells (CSCs) are the main source of drug resistance. The aim of this study was to establish a gemcitabine‐hydrochloride‐resistant (rt) human non‐small cell lung cancer (hNSCLC) cell line and their CSC line to be used as disease models in various cancer studies. In the first phase of study, a gemcitabine hydrochloride‐rt hNSCLC line cells was produced by making them rt through periodic exposure to gemcitabine hydrochloride. This acquired gemcitabine‐hydrochloride‐rt hNSCLC cell line was characterized for resistance. Subsequently, a CSC population with a CD326 + CD133 + CD44+ phenotypes was immunoselectively isolated from gemcitabine hydrochloride‐rt hNSCLCs purified from a single cell by colony forming technology. This rt CSC line was characterized for both resistance and stemness. Rt and non‐rt CSCs were analyzed and compared with each other in terms of immunophenotyping the expression profiles of ALDH1, CD90, ABCG2, CD44 and MDR1, which are CSC specific markers, of demonstrating mitotic capacity with growth curve analysis and of their ability to form tumor spheroids in three different 3D cultures. The results of this study demonstrated for the first time the successful generation of both gemcitabine‐hydrochloride‐rt hNSCLC cells and CSCs derived from gemcitabine‐hydrochloride‐rt hNSCLC cells. It was also shown that isolated and characterized rt CSCs could proliferate and form tumor spheres in vitro using three different 3D in vitro techniques. It was shown that the cell surface markers CD326, CD133 and CD44 can serve as an antibody panel for CSCs.Keywords
This publication has 68 references indexed in Scilit:
- Gemcitabine resistance in non‐small cell lung cancer is mediated through activation of the PI3K/AKT/NF‐κB pathway and suppression of ERK signaling by reactive oxygen speciesJournal of Biochemical and Molecular Toxicology, 2023
- Three-Dimensional Spheroid Culture Increases Exosome Secretion from Mesenchymal Stem CellsTissue Engineering and Regenerative Medicine, 2018
- CD44: More than a mere stem cell markerThe International Journal of Biochemistry & Cell Biology, 2016
- Optimization of the formation of embedded multicellular spheroids of MCF-7 cells: How to reliably produce a biomimetic 3D modelAnalytical Biochemistry, 2016
- 3D Cell Culture Systems: Advantages and ApplicationsJournal of Cellular Physiology, 2014
- Cancer stem cell characteristics, ALDH1 expression in the invasive front of nasopharyngeal carcinomaVirchows Archiv, 2013
- Aberrant microRNAs Expression in CD133+/CD326+ Human Lung Adenocarcinoma Initiating Cells from A549Molecules and Cells, 2012
- Pancreatic Cancer Cells Resistant to Chemoradiotherapy Rich in “Stem-Cell-Like” Tumor CellsDigestive Diseases and Sciences, 2010
- CD44‐positive cells are responsible for gemcitabine resistance in pancreatic cancer cellsInternational Journal of Cancer, 2009
- Characterization of a stem cell population in lung cancer A549 cellsBiochemical and Biophysical Research Communications, 2008